Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe
On March 4, 2021, EuropaBio hosted the event ‘Measuring the Economic Footprint of the Biotechnology Industry in Europe’ to showcase the same-titled report.
The study, from the WifOR Institute, looked at the economic impact of the biotechnology industry within the (then) 28 European member states, in terms of gross value added (GVA), employment and trade in 2018.
European GDP benefitted by €38.5 bn and, including spill over effects, that number rises to €78.7bn. The direct contribution adds up to about 1.5% of total industrial GVA within the countries assessed, supported by 223,000 direct jobs rising to over 700,000 with associated employment.
The event brought together the report authors to present their findings in full, and a panel discussion with EuropaBio Members BASF, Gilead, and Bio.be/Essenscia to plot the future economic pathway for biotechnology across sectors.
The webinar then closed with EuropaBio Council Directors Bernard Grimm and Agnes Borg presenting industry policy and regulatory priorities from Members, where EuropaBio works to achieve the robust ecosystem biotechnology economic and societal contributions.
The full webinar recording is available HERE.
The webinar slides are available for download BELOW.